Medications Updated During February 2020, From Newest to Oldest

Page 1 of 94 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Irinotecan Hydrochloride

Irinotecan Hydrochloride Injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based…

Actavis Pharma, Inc.29 February 2020

Dacarbazine

Dacarbazine for injection is indicated in the treatment of metastatic malignant melanoma. In addition. Dacarbazine for injection is also indicated for Hodgkin’s disease as a…

Teva Parenteral Medicines, Inc.29 February 2020

Ondansetron (Ondansetron Hydrochloride)

Ondansetron oral solution USP is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to…

Lannett Company, Inc.29 February 2020

Aspirin and Dipyridamole

Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to…

Teva Pharmaceuticals USA, Inc.29 February 2020

Propofol

Propofol Injectable Emulsion is an IV general anesthetic and sedation drug that can be used as described in the table below. Table 3. Indications for Propofol Injectable Emulsion…

Actavis Pharma, Inc.29 February 2020

Page 1 of 94 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.